TEM8-targeting antibody-drug conjugates (Baylor Scott & White Research Institute)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTEM8-targeting antibody-drug conjugates (Baylor Scott & White Research Institute)

Drug Alias NamecAF334-MMAE

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionAnthrax toxin receptor 1 modulators

TargetsAnthrax toxin receptor 1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBaylor Scott & White Research Institute

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBaylor Scott & White Research Institute

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A